DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Fanikos J, Murwin D, Gruenenfelder F. , et al.
Global use of idarucizumab in clinical practice: outcomes of the RE-VECTO surveillance program.
Thromb Haemost 2019;
120 (02) 27-35
Access:
We do not assume any responsibility for the contents of the web pages of other providers.